TECVAYLI (Teclistamab) Everything You Need to Know
HTML-код
- Опубликовано: 8 фев 2025
- Watch the full course and our most up-to-date content here: linktr.ee/Heal...
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: healthtree.org...
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
On February 20, 2024 the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for TECVAYLI® (teclistamab) for a reduced dosing frequency of 1.5 mg/kg every two weeks in patients with relapsed or refractory multiple myeloma who have achieved and maintained a complete response or better for a minimum of six months.There is a continued unmet need for patients with multiple myeloma and this approval allows increased flexibility in dosing schedule for appropriate patients with a weight-based regimen.
I'll try this treatment next month, so this video answered a lot of my questions. It was very helpful, thank you.
Great presentation. Thanks
Worst advice to give was to keep up on Covid vaccines
Why you wanted to isolate T-cells? To GMO production or organs? What is truth reason? Karyopharm and Amgen? Ot looks like very far from treatment. Why you can't treat HIV? Acyklovir does not work?